---
schema_version: "secwatch.filing_event.v1"
accession: "0001764013-25-000009"
form_type: "8-K"
ticker: "IMVT"
cik: "0001764013"
company_name: "Immunovant, Inc."
filed_at: "2025-01-14T23:59:59+00:00"
generated_at: "2026-05-28T02:10:08.461312+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Immunovant presents corporate overview at J.P. Morgan Healthcare Conference; no new data disclosed

## Summary
- Presentation on January 14, 2025 covers autoimmune pipeline and tailored science approach.
- No specific clinical results, financial updates, or guidance changes provided in the filing.
- Filed under Regulation FD; presentation not incorporated by reference into SEC filings.

## SEC filing metadata
- accession: 0001764013-25-000009
- form_type: 8-K
- ticker: IMVT
- cik: 0001764013
- company_name: Immunovant, Inc.
- filed_at: 2025-01-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1764013/000176401325000009/0001764013-25-000009-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1764013/000176401325000009/imvt-20250114.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001764013-25-000009
- JSON: https://secwatch.observer/filing/0001764013-25-000009.json
- Plain text: https://secwatch.observer/filing/0001764013-25-000009.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.